Professor of Medicine - Director, Pulmonary Vascular Program, Cleveland Clinic
Pulmonology
Dr. Raed A. Dweik, MD
|
|
Give Review
Raed Dweik practices Pulmonology. He has 4 awards "CMS Meaningful Use Stage 1 Certification", "Fellow (FACP)", "Fellow" and "Fellow (FCCM)". Raed Dweik is a published physician. He has 101 papers published. The most current publication "Analysis of the safety of bronchoscopy after recent acute myocardial infarction." Raed Dweik accepts Medicare payments and is registered with Medicare.gov.
Publications
- Eotaxin-Rich Proangiogenic Hematopoietic Progenitor Cells and CCR3+ Endothelium in the Atopic Asthmatic Response.
- Right atrial pressure/Pulmonary artery wedge pressure ratio: A more specific predictor of survival in Pulmonary arterial hypertension.
- Letter: volatile metabolomics of exhaled breath or faecal gas? - authors' reply.
- O-GlcNAc Transferase Directs Cell Proliferation in Idiopathic Pulmonary Arterial Hypertension.
- Volatile Organic Compounds in Urine for Noninvasive Diagnosis of Malignant Biliary Strictures: A Pilot Study.
- Are Transcutaneous O2 and CO2 determinations of value in Pulmonary Arterial Hypertension?
- Review article: breath analysis in inflammatory bowel Diseases.
- Volatile organic compounds in bile for early diagnosis of cholangiocarcinoma in patients with Primary sclerosing cholangitis: a pilot study.
- Pulmonary hypertension in sickle cell disease.
- Is Pulmonary hypertension a metabolic disease?
- Imatinib in Pulmonary arterial hypertension: c-Kit inhibition.
- Metabolomic analysis of breath volatile organic compounds reveals unique breathprints in children with inflammatory bowel Disease: a pilot study.
- Electrocardiographic Differences between COPD Patients Evaluated for Lung Transplantation With and without Pulmonary Hypertension.
- Volatile organic compounds in bile can diagnose malignant biliary strictures in the setting of pancreatic Cancer: a preliminary observation.
- Heart rate slopes during 6-min walk test in Pulmonary arterial hypertension, other lung diseases, and healthy controls.
- Prognostic Value of Echocardiographic Changes in Patients with Pulmonary Arterial Hypertension Receiving Parenteral Prostacyclin Therapy.
- Breathprints of childhood obesity: changes in volatile organic compounds in obese children compared with lean controls.
- Sublingual Microcirculation in Pulmonary Arterial Hypertension.
- Presence and Outcomes of Kidney Disease in Patients with Pulmonary Hypertension.
- Clinical characterization and survival of patients with borderline elevation in Pulmonary artery pressure.
- Value of Impedance Cardiography during 6-Minute Walk Test in Pulmonary Hypertension.
- Plasma interleukin-6 adds prognostic information in Pulmonary arterial hypertension.
- Why patients who die of worsening Pulmonary arterial hypertension are not on parenteral prostacyclin analog treatment?
- The Breathprints in Patients with Liver Disease Identify Novel Breath Biomarkers in Alcoholic Hepatitis.
- Subcutaneous to Intravenous Prostacyclin Analogue Transition in Pulmonary Hypertension.
- Causes and Circumstances of Death in Pulmonary Arterial Hypertension.
- Single exhaled breath metabolomic analysis identifies unique breathprint in patients with acute decompensated Heart failure.
- Loss of alveolar membrane diffusing capacity and Pulmonary capillary blood volume in Pulmonary arterial hypertension.
- Nitric oxide deficiency in Pulmonary hypertension: Pathobiology and implications for therapy.
- Impact of switching from epoprostenol to IV treprostinil on treatment satisfaction and quality of life in patients with Pulmonary hypertension.
- Subdural hematomas in Pulmonary arterial hypertension patients treated with prostacyclin analogs.
- Spleen Size in Idiopathic and Heritable Pulmonary Arterial Hypertension.
- Effect of Obesity on B-Type Natriuretic Peptide Levels in Patients With Pulmonary Arterial Hypertension.
- Nitric oxide and Asthma severity: towards a better understanding of Asthma phenotypes.
- Leptin levels predict survival in Pulmonary arterial hypertension.
- Sensitive cardiac troponin I predicts poor outcomes in Pulmonary arterial hypertension.
- ABNORMAL PLATELET AGGREGATION IN IDIOPATHIC Pulmonary ARTERIAL HYPERTENSION: ROLE OF NITRIC OXIDE.
- Prevalence and Prognostic Value of Left Ventricular Diastolic Dysfunction in Idiopathic and Heritable Pulmonary Arterial Hypertension.
- Heart Rate Recovery Predicts Clinical Worsening in Patients with Pulmonary Arterial Hypertension.
- Severe Asthma: Lessons Learned from the NHLBI Severe Asthma Research Program.
- PortoPulmonary Hypertension: A Report From the US-Based REVEAL Registry.
- Update on Pulmonary vascular diseases 2010.
- Strengths and limitations of the six-minute-walk test: a model biomarker study in idiopathic Pulmonary fibrosis.
- Low-molecular-mass of hyaluronan was detected in PASMCs from the patients with idiopathic Pulmonary arterial hypertension.
- Exhaled nitric oxide in Pulmonary diseases: a comprehensive review.
- Plasma levels of high-density lipoprotein cholesterol and outcomes in Pulmonary arterial hypertension.
- CXC-chemokine ligand 10 in idiopathic Pulmonary arterial hypertension: marker of improved survival.
- Exhaled breath analysis: The new interface between medicine and engineering.
- Effects of the menstrual cycle on lung function variables in women with Asthma.
- Sarcoidosis-associated Pulmonary hypertension. One size does not fit all.
- Venous thrombo-embolic Disease.
- High levels of hyaluronan in idiopathic Pulmonary arterial hypertension.
- Deficiency of lung antioxidants in idiopathic Pulmonary arterial hypertension.
- Exhaled nitric oxide in Asthma. From diagnosis, to monitoring, to screening: are we there yet?
- Evaluation of delivery of enteral nutrition in critically ill patients receiving mechanical ventilation.
- Pulmonary gas transfer related to markers of angiogenesis during the menstrual cycle.
- Alterations of cellular bioenergetics in Pulmonary artery endothelial cells.
- Pulmonary hypertension: evaluation and management.
- Diagnosis and management of Pleural effusions: a practical approach.
- The Lung in the balance: arginine, methylated arginines, and nitric oxide.
- Validation study of fractional exhaled nitric oxide measurements using a handheld monitoring device.
- Role of epithelial nitric oxide in airway viral Infection.
- Exhaled nitric oxide measurement in workers in a microwave popcorn production plant.
- Pleural effusions: evaluation and management.
- Abnormalities in nitric oxide and its derivatives in Lung cancer.
- Correlation of systemic superoxide dismutase deficiency to airflow obstruction in Asthma.
- Detection of Lung cancer by sensor array analyses of exhaled breath.
- Increased arginase II and decreased NO synthesis in endothelial cells of patients with Pulmonary arterial hypertension.
- Nitric oxide and Pulmonary arterial pressures in Pulmonary hypertension.
- Hypothyroidism and Pulmonary arterial hypertension.
- Clinical application of beryllium lymphocyte proliferation testing.
- Beryllium dermatitis.
- Dysregulation of endogenous carbon monoxide and nitric oxide production in patients with advanced ischemic or nonischemic cardiomyopathy.
- Temporal association of nitric oxide levels and airflow in Asthma after whole lung allergen challenge.
- Primary Pulmonary hypertension: an overview of epidemiology and pathogenesis.
- Low levels of nitric oxide and carbon monoxide in alpha 1-antitrypsin deficiency.
- Biochemical efficacy and safety of a new pooled human plasma alpha(1)-antitrypsin, Respitin.
- Nitric oxide attenuates beryllium-induced IFNgamma responses in Chronic beryllium disease: evidence for mechanisms independent of IL-18.
- An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications.
- The great challenge for exhaled breath analysis: embracing complexity, delivering simplicity.
- Detrimental effects of environmental tobacco smoke in relation to Asthma severity.
- Determinants of exhaled breath condensate pH in a large population with Asthma.
- A comparison of the sensitivity, specificity, and molecular weight accuracy of three different commercially available Hyaluronan ELISA-like assays.
- Safety of investigative bronchoscopy in the Severe Asthma Research Program.
- Clinical applications of breath testing.
- Pulmonary hypertension and the search for the selective Pulmonary vasodilator.
- Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with Asthma.
- Applied breath analysis: an overview of the challenges and opportunities in developing and testing sensor technology for human health monitoring in aerospace and clini...
- A technical report on exhaled nitric oxide measurement: Asthma monitoring in athletes.
- Exhaled nitric oxide in Asthma: progress since the introduction of standardized methodology.
- Identification of Asthma phenotypes using cluster analysis in the Severe Asthma Research Program.
- Alterations of the arginine metabolome in Asthma.
- Long-term experience after transition from parenteral prostanoids to oral agents in patients with Pulmonary hypertension.
- Characterization of the severe Asthma phenotype by the National Heart, Lung, and Blood Institute''s Severe Asthma Research Program.
- Leptin deficiency recapitulates the histological features of Pulmonary arterial hypertension in mice.
- Exhaled breath condensate: methodological recommendations and unresolved questions.
- Necrosis of the bronchus. Role of radiation.
- Rare Pulmonary manifestation of Ehlers-Danlos syndrome.
- Nitric oxide, hypoxia, and superoxide: the good, the bad, and the ugly!
- Analysis of the safety of bronchoscopy after recent acute myocardial infarction.
Schools
University of Jordan
Procedures Preformed
- Bronchoscopy
- Thoracentesis
- Ventilation Management
Conditions Treated
- Acidosis
- Alkalosis
- Asthma
- Atelectasis
- View All
Doctors Specialties
- Critical Care Medicine
- Pulmonology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACP)
- Fellow
- Fellow (FCCM)
Education
-
Cleveland Clinic Foundation -
Wright State University -
University of Jordan Faculty of Medicine
Hospital
-
Cleveland Clinic
Drug Facts
| NPI NUMBER | 1982668505 | |
| NPPES Provider LastName | DWEIK | |
| NPPES Provider FirstName | RAED | |
| NPPES Provider ZIPCode | 441950001 | |
| NPPES Provider State | OH | |
| Specialty Description | Pulmonary Disease | |
| Total Claim Count | 166.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1982668505 |
| Last Name Of The Provider | DWEIK |
| First Name Of The Provider | RAED |
| View All |
Similar Doctors
|
|
Dr. Stephen J. Clary, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gohar H. Dar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Murray D. Altose, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nauman Hamid, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Lawrence M. Martin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vineesha Arelli, MD |
|
|
Dr. Geoffrey D. Lively, MD |